Resolved
ZOLADEX Goserelin 3.6mg (as Acetate) Implant Syringe
goserelin · 3.6 mg Implant
- Supply impact started
- 22 Sept 2026
- Supply impact ended
- 22 Sept 2026
- Deletion from market
- 1 Nov 2026
- TGA row last updated
- 23 Sept 2026
- ARTG ID
- 24368
- Sponsor
- AstraZeneca Pty Ltd
- Sponsor phone
- 1800805342
- Shortage impact
- Critical
- Availability
- Available
Reason reported to TGA
Commercial Changes / Commercial viability
TGA management action
The sponsor has advised that this product will continue to be supplied. Further details are available through the following link: www.astrazeneca.com.au/news/media-releases/2026/ASTRAZENECA-TO-EXTEND-PBS-ACCESS-TO-ZOLADEX-goserelin-MONTHLY-3_6mg-IMPLANT.html
What to do
- 1.This TGA report is resolved — The export lists this shortage as resolved. Ask your pharmacist if you had been switched to another product.
Official sources
Last updated from the TGA Medicine Shortage Reports Database (report generated 12 November 2026 10:24:39 PM).
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.